Drug-labels.com

Act Telmisartan: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
40 mg, 80 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Act Telmisartan

ABOUT THIS MEDICATION

What the medication is used for:

  • To treat high blood pressure

What it does:

ACT TELMISARTAN is an angiotensin receptor blocker (ARB). You can recognize an ARB because its medicinal ingredient ends in “-SARTAN”.

This medicine does not cure your disease. It helps to control it. Therefore, it is important to continue taking ACT TELMISARTAN regularly even if you feel fine.

When it should not be used:

Do not take ACT TELMISARTAN if you:

  • Are allergic to telmisartan or to any non-

    medicianl ingredient in the formulation.

  • Have experienced an allergic reaction with

    swelling of the face, lips, tongue, throat, or sudden difficulty breathing or swallowing to any ARB. Be sure to tell your doctor, nurse, or pharmacist that this happened to you.

  • Are pregnant or intend to become pregnant.

    Taking ACT TELMISARTAN during pregnancy can cause injury and even death to your baby.

  • Are breastfeeding. It is possible that

    ACT TELMISARTAN passes into breast milk.

  • Are allergic to some sugars (mannitol

    intolerant).

What the medicinal ingredient is:

Telmisartan

What the important nonmedicinal ingredients are: Crospovidone, magnesium stearate, mannitol, meglumine, povidone, sodium hydroxide and talc.

If you are on a special diet, or if you are allergic to any substance, ask your doctor or pharmacist whether any of these ingredients may cause a problem for you.

What dosage forms it comes in: Tablets in 40 mg and 80 mg strengths

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions - Pregnancy

ACT TELMISARTAN should not be used during pregnancy. If you discover that you are pregnant while taking ACT TELMISARTAN, stop the medication and please contact your doctor, nurse, or pharmacist as soon as possible.

BEFORE you use ACT TELMISARTAN talk to your doctor or pharmacist if you:

  • Have experienced an allergic reaction to any drug used to lower blood pressure.
  • Have narrowing of a heart valve, diabetes, liver or kidney disease, heart or blood vessel disease.
  • Are dehydrated or if you suffer from excessive vomiting, diarrhea or sweating.
  • Are taking a salt substitute that contains potassium, potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill” that makes your body keep potassium).
  • Are on a low salt diet.
  • Are on dialysis.
  • Are less than 18 years old.
  • Have been told by your doctor that you have intolerance to some sugars.

Before you perform tasks which require special attention (driving a car or operating dangerous machinery), wait until you know how you respond to ACT TELMISARTAN. Dizziness, lightheadedness, or fainting can especially occur after the first dose and when the dose is increased.

INTERACTIONS WITH THIS MEDICATION

As with most medicines, interaction with other drugs is possible. Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with ACT TELMISARTAN:

  • Blood pressure lowering drugs, including diuretics (“water pills”).
  • Lithium, used to treat mood disorder.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) used to reduce pain and swelling. Examples include acetylsalicylic acid (ASA), celecoxib, naproxen and ibuprofen.
  • Digoxin to treat many heart conditions.
  • Warfarin, used to prevent blood clots (blood thinner).

ACT TELMISARTAN Product Monograph Page 29 of 30

PROPER USE OF THIS MEDICATION

Take ACT TELMISARTAN exactly as prescribed. It is recommended to take your dose at about the same time everyday with or without food, but it should be taken the same way each day. Do not stop taking your medication before informing your doctor, nurse, or pharmacist.

Usual adult dose:

The recommended dose of ACT TELMISARTAN is 80 mg once daily. Your doctor may prescribe 40 mg once daily if you have liver disease.

Overdose:

If you think you have taken too much ACT TELMISARTAN contact your doctor, nurse, pharmacist, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you have forgotten to take your dose during the day, carry on with the next one at the usual time. Do not double dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side effects may include:

  • Back or leg pain, muscle cramps, joint pain, muscle spasms
  • Headache, anxiety
  • Diarrhea, constipation, nausea, vomiting, upset stomach, abdominal pain, flatulence
  • Dry mouth
  • Rash, eczema, skin eruptions
  • Drowsiness, insomnia, fatigue
  • Visual disturbances
  • Upper respiratory infection

If any of these affects you severely, tell your doctor, nurse or pharmacist.

ACT TELMISARTAN can cause abnormal blood test results. Your doctor will decide when to perform blood tests and will interpret the results.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor, nurse or pharmacistStop taking drug and seek immediate medical help
Only if severeIn all cases

Very

Common

Chest pain✓
Common

Low Blood

Pressure:

Dizziness,

Fainting, lightheadedness

✓
Shortness of breath✓
Uncommon

Depression:

Low mood, loss of interest in activities, change in appetite and sleep patterns

✓

Kidney

Disorder:

Change in frequency of urination, nausea, vomiting, swelling of extremities, fatigue

✓

Increased levels of potassium in the blood:

Irregular heartbeats, muscle weakness and generally feeling unwell

✓

Urinary Tract Infections

(Cystitis):

Frequent or painful urination, feeling unwell

✓
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor, nurse or pharmacist

Stop taking drug and

seek

immediate medical help

Only if severeIn all cases
Rare

Liver disorder: Yellowing of the skin or eyes, dark urine, abdominal pain, nausea,

vomiting, loss of appetite

✓

Low blood

sugar:

Shaky, irregular heartbeat,

sweating, hunger, dizziness (in

diabetic

patients)

✓
Unknown

Allergic

Reaction:

Rash, hives,

swelling of the face, lips, tongue or throat,

difficulty

swallowing or breathing

(potentially with fatal outcome)

✓

Sepsis (blood poisoning):

Chills, confusion, fever or low body

temperature, shakiness,

irregular

heartbeat

(including fatal outcome)

✓

Rhabdomyolysis

: Muscle pain that you cannot explain, muscle tenderness or weakness or dark brown urine

✓

This is not a complete list of side effects. For any unexpected effects while taking ACT TELMISARTAN, contact your doctor, nurse or pharmacist.

HOW TO STORE IT

ACT TELMISARTAN tablets should be stored at room temperature (15°C - 30°C). Tablets should not be removed from blisters until immediately prior to administration. Avoid excessive heat and moisture.

Keep out of reach of children and pets.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

----------------------------------------------------------------------------

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program Health Canada

      Postal Locator 0701E

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

----------------------------------------------------------------------------

NOTE: Should you require information related to the
management of side effects, contact your health professional.
The Canada Vigilance Program does not provide medical
advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, Actavis Pharma Company, at: 1-866-254-6111

Actavis Pharma Company.

6733 Mississauga Road, Mississauga, ON, Canada, L5N 6J5

Last revised: May 1, 2014

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02393247

Revision date stated in the text: May 1, 2014

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Act Telmisartan

Rx or OTC
Prescription (Rx)?
DIN 02393247, 02393255
Schedule(s) PRESCRIPTION
Active ingredient(s) Telmisartan
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09C Angiotensin II receptor blockers (ARBs), plain
        1. C09CA Angiotensin II receptor blockers (ARBs), plain
          1. C09CA07 Telmisartan
Company ACTAVIS PHARMA COMPANY
Current status Cancelled Post Market
Current status date June 11, 2018
Strengths and forms
DIN Strength Dosage form(s) Current status
02393247 40 MG Tablet Cancelled Post Market June 11, 2018
02393255 80 MG Tablet Cancelled Post Market June 11, 2018

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.